Number (%) of isolates resistant to specified first line drugs (monoresistant or any resistance) by sex and age group, 1993–9, UK
| Isoniazid | Rifampicin | Ethambutol | Pyrazinamide | Streptomycin | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Drug and resistance (all/monoresistance) | Any* | Mono† | Any* | Mono† | Any* | Mono† | Any* | Mono† | Any* | Mono† |
| *Any: resistance to specified drug, with or without resistance to other drugs. | ||||||||||
| †Mono: resistance to specified drug alone. | ||||||||||
| Sex | ||||||||||
| Men | 707 | 365 | 207 | 23 | 87 | 4 | 88 | 24 | 423 | 195 |
| (n=7167) | (9.9) | (5.1) | (2.9) | (0.3) | (1.2) | (0.1) | (1.2) | (0.3) | (5.9) | (2.7) |
| Women | 448 | 243 | 85 | 9 | 40 | 3 | 45 | 17 | 296 | 135 |
| (n=4936) | (9.1) | (4.9) | (1.7) | (0.2) | (0.8) | (0.1) | (0.9) | (0.3) | (6.0) | (2.7) |
| Unknown | 41 | 27 | 7 | 1 | 2 | 0 | 4 | 2 | 29 | 17 |
| (n=589) | (7.0) | (4.6) | (1.2) | (0.2) | (0.3) | – | (0.7) | (0.3) | (4.9) | (2.9) |
| Age group | ||||||||||
| 0–14 years | 29 | 14 | 4 | 0 | 2 | 1 | 3 | 2 | 35 | 21 |
| (n=273) | (10.6) | (5.1) | (1.5) | – | (0.7) | (0.4) | (1.1) | (0.7) | (12.8) | (7.7) |
| 15–44 years | 807 | 420 | 195 | 25 | 77 | 4 | 77 | 24 | 531 | 245 |
| (n=7080) | (11.4) | (5.9) | (2.8) | (0.4) | (1.1) | (0.1) | (1.1) | (0.3) | (7.5) | (3.5) |
| 45–64 years | 213 | 114 | 59 | 2 | 34 | 1 | 35 | 8 | 102 | 36 |
| (n=2480) | (8.6) | (4.6) | (2.4) | (0.1) | (1.4) | (<0.1) | (1.4) | (0.3) | (4.1) | (1.5) |
| 65+ years | 105 | 63 | 29 | 4 | 12 | 1 | 17 | 7 | 46 | 23 |
| (n=2195) | (4.8) | (2.9) | (1.3) | (0.2) | (0.5) | (<0.1) | (0.8) | (0.3) | (2.1) | (1.0) |
| Age unknown | 42 | 24 | 12 | 2 | 4 | 0 | 5 | 2 | 34 | 22 |
| (n=664) | (6.3) | (3.6) | (1.8) | (0.3) | (0.6) | – | (0.8) | (0.3) | (5.1) | (3.3) |
| Total | ||||||||||
| (n=12692) | 1196 | 635 | 299 | 33 | 129 | 7 | 137 | 43 | 748 | 347 |
| (9.4) | (5.0) | (2.4) | (0.3) | (1.0) | (0.1) | (1.1) | (0.3) | (5.9) | (2.7) | |